Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)
Close on Nov 16, 2026Market cap $18.22MP/E –Yield –
Edesa Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Edesa Biotech's ebitda for the twelve months ending Jun 30, 2026 was -$14.53M. For fiscal 2025 it was -$7.79M. The highest annual figure on record is -$4.76M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$7.79M | – |
| FY2024 | Sep 30, 2024 | -$6.83M | – |
| FY2023 | Sep 30, 2023 | -$9.04M | – |
| FY2022 | Sep 30, 2022 | -$18.25M | – |
| FY2021 | Sep 30, 2021 | -$23.56M | – |
| FY2020 | Sep 30, 2020 | -$6.34M | – |
| FY2018 | Sep 30, 2018 | -$4.89M | – |
| FY2017 | Sep 30, 2017 | -$5.05M | – |
| FY2016 | Sep 30, 2016 | -$4.76M | – |
| FY2014 | Aug 31, 2014 | -$5.56M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$5.49M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$4.27M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$2.32M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$2.44M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.88M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$1.61M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$1.86M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$960.19K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$1.88M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$2.18M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$1.81M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$2.32M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$1.98M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$2.38M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$2.35M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$2.81M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$5.77M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$4.55M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$5.13M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$5.46M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$6.04M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$9.48M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$2.58M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$1.98M | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.74M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.51M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$1.10M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$1.32M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$540.27K | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$405.33K | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$1.14M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$375.35K | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$1.30M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.34M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$1.33M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$1.25M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$1.10M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$1.37M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$1.27M | – |
See a number that looks wrong?